A detailed history of Principal Securities, Inc. transactions in Novo Cure LTD stock. As of the latest transaction made, Principal Securities, Inc. holds 80 shares of NVCR stock, worth $1,502. This represents 0.0% of its overall portfolio holdings.

Number of Shares
80
Previous 86 6.98%
Holding current value
$1,502
Previous $1.47 Million 15.14%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$15.61 - $23.34 $93 - $140
-6 Reduced 6.98%
80 $1.25 Million
Q2 2024

Jul 31, 2024

BUY
$11.83 - $24.05 $626 - $1,274
53 Added 160.61%
86 $1.47 Million
Q1 2024

May 10, 2024

BUY
$12.42 - $17.29 $12 - $17
1 Added 3.13%
33 $516,000
Q4 2023

Feb 07, 2024

BUY
$11.13 - $15.78 $356 - $504
32 New
32 $478,000

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $1.97B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Principal Securities, Inc. Portfolio

Follow Principal Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Principal Securities, Inc. with notifications on news.